Dr. Greg Koblentz, the Council on Foreign Relations Stanton Nuclear Fellow and GMU Biodefense’s Deputy Director, was recently featured in a number of pieces on Syria and Iran.
Dr. Koblentz was quoted in the French periodical, Le Point, in which he discussed the degree of independent confirmation needed to determine the use of chemical weapons, and the unique difficulties for doing so in Syria, due to the ongoing hostilities. Read the full article here (in French). He echoed these sentiments in a USA Today piece on Israeli intelligence regarding Syrian use of chemical weapons (available here).
Dr. Koblentz was also quoted in an Executive Magazine article on Iranian sanctions –
“‘The size of Iran’s stockpile of 20 percent [highly enriched uranium] is worrisome because it is much easier to enrich 20 percent to 90 percent than five percent to 20 percent,’ says Gregory Koblentz, a nuclear security expert at the Washington-based Council on Foreign Relations. ‘So if Iran decided to build a bomb, it would be able to do so much more quickly if it is sitting on a large quantity of 20 percent than five percent Uranium-235.'”